Singapore markets closed
Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,703.97 +476.73 (+0.71%) CMC Crypto 200
1,426.24 -2.33 (-0.16%)
ALXO Aug 2024 14.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:43PM EDT
| Previous close | 5.62 |
| Open | 5.62 |
| Bid | 0.95 |
| Ask | 3.60 |
| Strike | 14.00 |
| Expiry date | 2024-08-16 |
| Day's range | 5.62 - 5.62 |
| Contract range | N/A |
| Volume | |
| Open interest | 102 |
ZacksNovartis (NVS) Reports Positive Long-Term Data on CSU Drug
Novartis (NVS) reports phase III data that confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria.
ZacksGilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Gilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or metastatic urothelial cancer fails to achieve its primary endpoint.
ZacksUltragenyx (RARE) DTX401 Meets Goals in Metabolic Disorder Study
Ultragenyx (RARE) reports meeting primary and secondary endpoints in the late-stage study of its investigational gene therapy, DTX401, to treat glycogen storage disease type Ia.
© 2024 Yahoo. All rights reserved.